Two Sigma Investments’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Two Sigma Investments’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-403	Closed	-$2.12K	–	3440
2023 Q3	$2.12K	Sell	403 -500	-55%	-$3.1K	﹤0.01%	2924
2023 Q2	$6.36K	Sell	903 -643	-42%	-$5.54K	﹤0.01%	2956
2023 Q1	$14.7K	Buy	+1,546	New	+$16.2K	﹤0.01%	2871
2022 Q1	–	Sell	-510	Closed	-$59K	–	4622
2021 Q4	$59K	Buy	+510	New	+$123K	﹤0.01%	4129

Other funds holding NEXI

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Investments's NEXI Position: Q4 2023 in Review

Two Sigma Investments sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2023, closing a stake of 403 shares — an estimated $2.12K sold.

Two Sigma Investments first reported a position in NEXI in Q4 2021 and held it in 4 quarters. The position peaked at $59K in Q4 2021. 11 funds tracked by Wall St. Rank hold NEXI as of Q4 2023.

Two Sigma Investments reported no remaining NexImmune, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Two Sigma Investments sold 403 NexImmune, Inc. Common Stock shares in Q4 2023, an estimated $2.12K.
Two Sigma Investments first reported a position in NexImmune, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
Two Sigma Investments's NexImmune, Inc. Common Stock position peaked at $59K in Q4 2021.
11 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2023.

Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.